Therefore, we have used exome and genome sequencing data (1) to identify rare and low-frequency coding variants in BIN1, CLU, CR1, PICALM, MS4A6A, ABCA7, EPHA1, CD33, and CD2AP and (2) to investigate their single independent and combined effect on AD susceptibility. This evidence concerns the gene CD33 and Alzheimer disease.